Sezzle Q3 Adj. EPS $1.37 Beats $1.29 Estimate, Sales $166.503M Beat $154.941M Estimate

Needham Maintains Buy Rating and Raises Price Target for Sezzle

Needham & Company maintained its "Buy" rating on Sezzle Inc. and increased its price target from $172 to $220.

Sezzle Reports Third Quarter 2026 Financial Results

Sezzle Inc. reported strong third-quarter 2026 financial results, featuring record revenue of $166.5 million and a 34.9% year-over-year increase in Total Transaction Volume (TTV).

Sezzle Sees FY2027 Adj EPS $7.20 vs $6.65 Est

Sezzle Raises FY2026 Adj EPS Guidance from $5.25 to $5.45-$5.50 vs $5.26 Est; Raises FY2026 Sales Guidance from $607.905M to $641.649M vs $608.942M Est

Sezzle Set to Report Q3 Earnings: What's in Store for the Stock?

Sezzle Inc. is expected to report Q3 2026 results on November 4 with revenues and EPS projected to rise 31.83% and 80.28% year-over-year, respectively. The company benefits from subscriber growth, higher transaction frequency, and new merchant partnerships. However, higher credit losses and lower revenue yield may offset gains. The Zacks model does not predict an earnings beat due to a -3.53% Earnings ESP despite a Rank #2 rating.

Breakfast News: We’re Right There With You

The Nasdaq-100 fell nearly 5% on Friday, marking its third 10% correction this year, though it has nearly doubled over three years. The article advises investors to stay invested during market volatility through strategies like dollar-cost averaging and diversification. Key earnings this week include Apple, Shopify, AMD, and Berkshire Hathaway. Kiniksa Pharmaceuticals' heart drug Arcalyst is projected to become a blockbuster with $1B+ sales. Investors should focus on long-term plans rather than election-driven trading.